Osaic Holdings’s Medicus Pharma MDCX Stock Holding History

Osaic Holdings’s Portfolio MDCX Stock Details MDCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.38K	Sell	7,500 -1,000	-12%	-$354	﹤0.01%	7092
2026 Q1	$3.91K	Hold	8,500	–	–	﹤0.01%	6796
2025 Q4	$13K	Sell	8,500 -5,500	-39%	-$11.8K	﹤0.01%	6170
2025 Q3	$31.4K	Hold	14,000	–	–	﹤0.01%	5625
2025 Q2	$41.9K	Buy	14,000 +9,000	+180%	+$35.9K	﹤0.01%	5174
2025 Q1	$18.6K	Buy	+5,000	New	+$15.7K	﹤0.01%	5412

Other funds holding MDCX

ICP

Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

SIAP

Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

MHC

May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WSFS

Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return

Osaic Holdings's MDCX Position: Q2 2026 in Review

Osaic Holdings reduced its Medicus Pharma (MDCX) stake by 12% in Q2 2026, selling an estimated $354 and leaving 7,500 shares worth $3.38K. The position accounts for ﹤0.01% of the portfolio, ranked #7092.

Osaic Holdings first reported a position in MDCX in Q1 2025 and has held it in 6 quarters since. The position peaked at $41.9K in Q2 2025. 24 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

Osaic Holdings held 7,500 shares of Medicus Pharma worth $3.38K as of Q2 2026.
Osaic Holdings sold 1,000 Medicus Pharma shares in Q2 2026, an estimated $354.
Medicus Pharma made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7092 holding.
Osaic Holdings first reported a position in Medicus Pharma in Q1 2025 and has held it in 6 quarters since.
Osaic Holdings's Medicus Pharma position peaked at $41.9K in Q2 2025.
24 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.